Ingevity closed at $73.73 on Nov 4, up 0.14%, 5.3% below its 52-week closing high. Volume of 725.0K shares was 2.40× its 20-day average (well above normal).
Split-adjusted performance: +1.3% over one month, -5.3% over six months, +36.9% over one year.
In the quarter ended Jun 30, 2026, revenue was $314.10M, down 5.2% from a year earlier, with a net margin of 11.2%.
Short interest was 1.4M shares at the Oct 15 settlement, down 6.3% from the prior report (4.0% of float, 5.3 days to cover).